APOA1 and amyloidosis: Conversely, increasing HDL levels in Aβ overexpressing mice, either through transgenic overexpression or upon treatment with an apoA-I mimetic, resulted in reduced CAA [37], lower amyloid plaque load [38–41], and attenuated neuroinflammation [37–39, 41].